Mitochondrial Toxins in Basal Ganglia Disorders: From Animal Models to Therapeutic Strategies

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|4|1|69-75

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.4, Iss.1, 2006-01, pp. : 69-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disorders of the basal ganglia and their modern management

By Schrag Anette   Quinn Niall  

Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. : 323-327

Royal College Of Physicians

Access to resources Recommend Favorite

Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1205-1218

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson's Disease and Other Motor Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 7, 2011-11 ,pp. : 777-791

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin Involvement in the Basal Ganglia Pathophysiology: Could the 5-HT2C Receptor be a New Target for Therapeutic Strategies?

By  

Current Medicinal Chemistry, Vol. 13, Iss. 25, 2006-10 ,pp. : 3069-3081

Bentham Science Publishers

Access to resources Recommend Favorite

Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential

By Crooke Almudena   Huete-Toral Fernando   Martínez-Águila Alejandro   Colligris Basilio   Pintor Jesus  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 10, 2012-10 ,pp. : 989-1001

Informa Healthcare

Access to resources Recommend Favorite